Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Valpromide: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 478058631 of page Valpromide for the Chem/Drugbox validation project (updated: 'KEGG', 'CASNo'). |
No edit summary |
||
Line 1: | Line 1: | ||
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:Valpromide|oldid=478058631}} 478058631] of page [[Valpromide]] with values updated to verified values.}} |
|||
{{Chembox |
{{Chembox |
||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
|||
| verifiedrevid = 480482210 |
|||
| ImageFile = Valpromide.svg |
| ImageFile = Valpromide.svg |
||
| ImageFile_Ref = {{chemboximage|correct|??}} |
| ImageFile_Ref = {{chemboximage|correct|??}} |
||
| ImageSize = 160 |
| ImageSize = 160 |
||
| ImageName = Skeletal formula of valpromide |
| ImageName = Skeletal formula of valpromide |
||
| |
| PIN = 2-Propylpentanamide<ref>{{cite web|title=dipropylacetamide - Compound Summary|url=https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=71113|work=PubChem Compound|publisher=National Center for Biotechnology Information|access-date=21 February 2012|location=USA|date=24 June 2005|at=Identification and Related Records}}</ref> |
||
⚫ | |||
| OtherNames = Depamide{{Citation needed|date=February 2012}} |
|||
| CASNo = 2430-27-5 |
|||
⚫ | |||
⚫ | |||
| CASNo = <!-- blanked - oldvalue: 2430-27-5 --> |
|||
| PubChem = 71113 |
|||
⚫ | |||
| |
| ChemSpiderID = 64264 |
||
| |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| UNII = RUA6CWU76G |
|||
| ChemSpiderID = 64264 |
|||
| |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| |
| EINECS = 219-394-2 |
||
| DrugBank = DB04165 |
|||
⚫ | |||
⚫ | |||
| EINECS = 219-394-2 |
|||
| |
| ChEBI = 74562 |
||
| KEGG = D02766 |
|||
⚫ | |||
⚫ | |||
| KEGG = <!-- blanked - oldvalue: D02766 --> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
| |
|Section2={{Chembox Properties |
||
| |
| C=8 | H=17 | N=1 | O=1 |
||
⚫ | |||
| ExactMass = 143.131014171 g mol<sup>−1</sup> |
|||
| MeltingPtC = 125 |
|||
⚫ | |||
| |
| LogP = 2.041 |
||
| LogP = 2.041 |
|||
}} |
}} |
||
| |
|Section6={{Chembox Pharmacology |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| EUClass = {{Hazchem Xn}} |
|||
| RPhrases = {{R22}} |
|||
⚫ | |||
}} |
}} |
||
| |
|Section7={{Chembox Hazards |
||
⚫ | |||
| OtherCpds = {{Unbulleted list|[[Valnoctamide]]|[[2-Ethylhexanoic acid]]}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
|Section8={{Chembox Related |
|||
| OtherFunction_label = [[amide]]s |
|||
| OtherFunction = [[Valnoctamide]] |
|||
| OtherCompounds = |
|||
}} |
}} |
||
}} |
|||
'''Valpromide''' (marketed as '''Depamide''' by [[Sanofi-Aventis]]) is a [[carboxamide]] derivative of [[valproic acid]] used in the treatment of [[epilepsy]] and some [[affective disorder]]s. It is rapidly metabolised (80%) to [[valproic acid]] (another [[anticonvulsant]]) but has anticonvulsant properties itself. It may produce more stable plasma levels than valproic acid or [[sodium valproate]] and may be more effective at preventing febrile seizures. However, it is over one hundred times more potent as an inhibitor of liver microsomal [[epoxide hydrolase]]. This makes it incompatible with [[carbamazepine]] and can affect the ability of the body to remove other toxins. Valpromide is no safer during pregnancy than valproic acid. |
|||
Valpromide is formed through the reaction of valproic acid and [[ammonia]] via an intermediate [[acid chloride]]. |
|||
In pure form, valpromide is a white crystalline powder and has a melting point 125–126 °C. It is soluble only in hot water. It is available on the market in some European countries. |
|||
==See also== |
|||
* [[Valproate pivoxil]] |
|||
* [[Valnoctamide]] |
|||
*[[Carbromide]] |
|||
*[[Ibrotamide]] |
|||
* M 25 [1186293-14-0] is also one of the compounds that has a reputation. |
|||
==References== |
|||
* ''The Medical Treatment of Epilepsy'' by Stanley R Resor. Published by Marcel Dekker (1991). {{ISBN|0-8247-8549-5}}. |
|||
* ''Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology'' by Bernard Testa, Joachim M. Mayer (2003). {{ISBN|3-906390-25-X}}. |
|||
* ''In Vitro Methods in Developmental Toxicology'' by Gary L Kimmel, Devendra M Kochhar, Baumann (1989). {{ISBN|0-8493-6919-3}}. |
|||
{{Reflist}} |
|||
{{Anticonvulsants}} |
|||
{{Mood stabilizers}} |
|||
{{GABA metabolism and transport modulators}} |
|||
{{HDAC inhibitors}} |
|||
{{Ion channel modulators}} |
|||
[[Category:Anticonvulsants]] |
|||
[[Category:GABA analogues]] |
|||
[[Category:GABA transaminase inhibitors]] |
|||
[[Category:Histone deacetylase inhibitors]] |
|||
[[Category:Mood stabilizers]] |
|||
[[Category:Carboxamides]] |
|||
{{anticonvulsant-stub}} |